相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-cell methods in myeloproliferative neoplasms: old questions, new technologies
Jennifer Mary O'Sullivan et al.
BLOOD (2023)
Genetic basis and molecular profiling in myeloproliferative neoplasms
Damien Luque Paz et al.
BLOOD (2023)
Life histories of myeloproliferative neoplasms inferred from phylogenies
Nicholas Williams et al.
NATURE (2022)
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis
Elena Genovese et al.
ANTIOXIDANTS (2022)
The longitudinal dynamics and natural history of clonal haematopoiesis
Margarete A. Fabre et al.
NATURE (2022)
In utero origin of myelofibrosis presenting in adult monozygotic twins
Nikolaos Sousos et al.
NATURE MEDICINE (2022)
Into the multiverse: advances in single-cell multiomic profiling
Silvia Ogbeide et al.
TRENDS IN GENETICS (2022)
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber et al.
BLOOD (2022)
Convergent Clonal Evolution of Signaling Gene Mutations Is a Hallmark of Myelodysplastic Syndrome Progression
Andrew J. Menssen et al.
BLOOD CANCER DISCOVERY (2022)
Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia
Tiffany Guess et al.
BLOOD CANCER DISCOVERY (2022)
Clonal independence of JAK2 and CALR or MPL mutations in comutated myeloproliferative neoplasms demonstrated by single cell DNA sequencing
Ella R. Thompson et al.
HAEMATOLOGICA (2021)
Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis
Nils B. Leimkuhler et al.
CELL STEM CELL (2021)
Single-Cell Multi-Omics Defines the Cell-Type Specific Impact of SF3B1 Splicing Factor Mutations on Hematopoietic Differentiation in Human Clonal Hematopoiesis and Myelodysplastic Syndromes
Federico Gaiti et al.
BLOOD (2021)
Oncometabolite L-2-hydroxyglurate directly induces vasculogenic mimicry through PHLDB2 in renal cell carcinoma
Huan Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms
Debra Van Egeren et al.
CELL STEM CELL (2021)
Mutated clones driving leukemic transformation are already detectable at the single-cell level in CD34-positive cells in the chronic phase of primary myelofibrosis
Sandra Parenti et al.
NPJ PRECISION ONCOLOGY (2021)
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis
Sebastiano Rontauroli et al.
BLOOD ADVANCES (2021)
Mouse Models of Frequently Mutated Genes in Acute Myeloid Leukemia
Sagarajit Mohanty et al.
CANCERS (2021)
Molecular pathogenesis of the myeloproliferative neoplasms
Graeme Greenfield et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis
Sebastian Fantini et al.
CANCERS (2021)
The Molecular Genetics of Myeloproliferative Neoplasms
Anna E. Marneth et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2020)
60 Years of clonal hematopoiesis research: From X- chromosome inactivation studies to the identification of driver mutations
Sami Ayachi et al.
EXPERIMENTAL HEMATOLOGY (2020)
Combined Cohesin-RUNX1 Deficiency Synergistically Perturbs Chromatin Looping and Causes Myelodysplastic Syndromes
Yotaro Ochi et al.
CANCER DISCOVERY (2020)
Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets
Bethan Psaila et al.
MOLECULAR CELL (2020)
Single-cell RNA counting at allele and isoform resolution using Smart-seq3
Michael Hagemann-Jensen et al.
NATURE BIOTECHNOLOGY (2020)
Polycythemia vera and essential thrombocythemia: 2021 update on diagnosis, risk-stratification and management
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Implications ofTP53allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
Elsa Bernard et al.
NATURE MEDICINE (2020)
Single-cell multiomics: technologies and data analysis methods
Jeongwoo Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Genomic Analysis of Hematopoietic Stem Cell at the Single-Cell Level: Optimization of Cell Fixation and Whole Genome Amplification (WGA) Protocol
Chiara Carretta et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
TARGET-Seq: A Protocol for High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing
Alba Rodriguez-Meira et al.
STAR PROTOCOLS (2020)
Single-cell mutation analysis of clonal evolution in myeloid malignancies
Linde A. Miles et al.
NATURE (2020)
ASXL1/EZH2 mutations promote clonal expansion of neoplastic HSC and impair erythropoiesis in PMF
Ioanna Triviai et al.
LEUKEMIA (2019)
Roles of cohesin in chromosome architecture and gene expression
Zhenhua Zhu et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2019)
Unravelling Intratumoral Heterogeneity through High-Sensitivity Single-Cell Mutational Analysis and Parallel RNA Sequencing
Alba Rodriguez-Meira et al.
MOLECULAR CELL (2019)
A Cellular Taxonomy of the Bone Marrow Stroma in Homeostasis and Leukemia
Ninib Baryawno et al.
CELL (2019)
Somatic mutations and cell identity linked by Genotyping of Transcriptomes
Anna S. Nam et al.
NATURE (2019)
Calreticulin Ins5 and De152 mutations impair unfolded protein and oxidative stress responses and oxidative stress responses in K562 cells expressing CALR mutants
Simona Salati et al.
SCIENTIFIC REPORTS (2019)
Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation
Aaron D. Viny et al.
CELL STEM CELL (2019)
Myelofibrosis in 2019: moving beyond JAK2 inhibition
Michael Schieber et al.
BLOOD CANCER JOURNAL (2019)
Towards a Better Understanding of Cohesin Mutations in AML
Sergi Cuartero et al.
FRONTIERS IN ONCOLOGY (2019)
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
Jiahao Chen et al.
NATURE MEDICINE (2019)
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients
S. Ruberti et al.
LEUKEMIA (2018)
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts
Ayalew Tefferi et al.
LEUKEMIA (2018)
Calreticulin Affects Hematopoietic Stem/Progenitor Cell Fate by Impacting Erythroid and Megakaryocytic Differentiation
Simona Salati et al.
STEM CELLS AND DEVELOPMENT (2018)
Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis
Mythri Mudireddy et al.
BLOOD CANCER JOURNAL (2018)
JAK2/IDH-mutant-driven myeloproliferative neoplasm is sensitive to combined targeted inhibition (vol 128, pg 789 2018)
Anna Sophia McKenney et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation
Sebastien Jacquelin et al.
BLOOD (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
J. Grinfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The mutational landscape of accelerated- and blast-phase myeloproliferative neoplasms impacts patient outcomes
Caroline J. McNamara et al.
BLOOD ADVANCES (2018)
Targeted next-generation sequencing in blast phase myeloproliferative neoplasms
Terra L. Lasho et al.
BLOOD ADVANCES (2018)
Impact of gene mutations on treatment response and prognosis of acute myeloid leukemia secondary to myeloproliferative neoplasms
Geoffroy Venton et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2017)
Leukemic Transformation in Myeloproliferative Neoplasms: A Literature Review on Risk, Characteristics, and Outcome
Meera Yogarajah et al.
MAYO CLINIC PROCEEDINGS (2017)
Simultaneous epitope and transcriptome measurement in single cells
Marlon Stoeckius et al.
NATURE METHODS (2017)
Myeloproliferative Neoplasms
Jerry L. Spivak
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
Cheng-Hong Tsai et al.
BLOOD CANCER JOURNAL (2017)
miR-494-3p overexpression promotes megakaryocytopoiesis in primary myelofibrosis hematopoietic stem/progenitor cells by targeting SOCS6
Sebastiano Rontauroli et al.
ONCOTARGET (2017)
Myeloproliferative neoplasms: from origins to outcomes
Jyoti Nangalia et al.
BLOOD (2017)
Overexpression of RUNX1 short isoform has an important role in the development of myelodysplastic/myeloproliferative neoplasms
Hiroko Sakurai et al.
BLOOD ADVANCES (2017)
Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development
B. A. Vishwakarma et al.
LEUKEMIA (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Targeted deep sequencing in primary myelofibrosis
Ayalew Tefferi et al.
BLOOD ADVANCES (2016)
Targeted deep sequencing in polycythemia vera and essential thrombocythemia
Ayalew Tefferi et al.
BLOOD ADVANCES (2016)
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eunhee Kim et al.
CANCER CELL (2015)
DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
Jyoti Nangalia et al.
HAEMATOLOGICA (2015)
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study
Lene Sofie Granfeldt Ostgard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
G&T-seq: parallel sequencing of single-cell genomes and transcriptomes
Iain C. Macaulay et al.
NATURE METHODS (2015)
Effect of Mutation Order on Myeloproliferative Neoplasms
Christina A. Ortmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
DNMT3A mutations occur early or late in patients with myeloproliferative neoplasms and mutation order influences phenotype
Jyoti Nangalia et al.
HAEMATOLOGICA (2015)
Distinct effects of concomitant Jak2V617F expression and Tet2 loss in mice promote disease progression in myeloproliferative neoplasms
Edwin Chen et al.
BLOOD (2015)
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis
Ayalew Tefferi et al.
BLOOD (2014)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg et al.
BLOOD (2014)
miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis
Ruggiero Norfo et al.
BLOOD (2014)
CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
A. Tefferi et al.
LEUKEMIA (2014)
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasms
Raajit Rampal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies
S. N. Khan et al.
LEUKEMIA (2013)
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms
Ayana Kon et al.
NATURE GENETICS (2013)
Expansion of functionally defined mouse hematopoietic stem and progenitor cells by a short isoform of RUNX1/AML1
Shinobu Tsuzuki et al.
BLOOD (2012)
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Omar Abdel-Wahab et al.
CANCER CELL (2012)
IDH mutation impairs histone demethylation and results in a block to cell differentiation
Chao Lu et al.
NATURE (2012)
Dnmt3a is essential for hematopoietic stem cell differentiation
Grant A. Challen et al.
NATURE GENETICS (2012)
An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment
Tiziana Grafone et al.
ONCOLOGY REVIEWS (2012)
Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies
Zhe Li et al.
BLOOD (2011)
Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid Transformation
Kelly Moran-Crusio et al.
CANCER CELL (2011)
Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm
Philip A. Beer et al.
BLOOD (2010)
AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms
Ye Ding et al.
BLOOD (2009)
p53 Regulates Hematopoietic Stem Cell Quiescence
Yan Liu et al.
CELL STEM CELL (2009)
Overexpression of an isoform of AML1 in acute leukemia and its potential role in leukemogenesis
X. Liu et al.
LEUKEMIA (2009)
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
G. Barosi et al.
LEUKEMIA (2008)
Leukemic blasts in transfon-ned JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation
Alexandre Theocharides et al.
BLOOD (2007)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Mutation of JAK2 in the myeloproliferative disorders:: timing, clonality studies, cytogenetic associations, and role in leukemic transformation
Peter J. Campbell et al.
BLOOD (2006)
Activating FLT3 mutations are detectable in chronic and blast phases of chronic myeloproliferative disorders other than chronic myeloid leukemia
Pei Lin et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity
ZQ Shi et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
